ID

37227

Descrição

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT02071862

Link

https://clinicaltrials.gov/show/NCT02071862

Palavras-chave

Versões (1)
  1. 09/07/2019 09/07/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

9 de julho de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Solid Tumors NCT02071862

Inglês

Eligibility Solid Tumors NCT02071862

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
advanced malignancy that is relapsed and/or refractory to all available therapies that will confer clinical benefit. newly diagnosed patients who refuse standard treatment regimens are also eligible
Descrição

Malignant Neoplasms Advanced Recurrent | Malignant Neoplasms Advanced Unresponsive to Treatment | Therapy All Benefit | Patients Standard therapy Refused

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0277556
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C0205269
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0444868
UMLS CUI [3,3]
C0814225
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C2936643
UMLS CUI [4,3]
C1705116
eastern cooperative oncology group (ecog) performance status of 0-1
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of at least 3 months
Descrição

Life Expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
adequate hepatic, renal, cardiac, and hematologic function
Descrição

Liver function | Renal function | Cardiac function | Hematologic function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232164
UMLS CUI [4]
C0221130
measurable disease by recist criteria
Descrição

Measurable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1513041
ability to provide written informed consent in accordance with federal, local, and institutional guidelines
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other current or previous malignancy
Descrição

Cancer Other

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1707251
chemotherapy, radiation therapy, hormonal therapy, immunotherapy or biological therapy, or investigational agent within 21 days
Descrição

Chemotherapy | Therapeutic radiology procedure | Hormone Therapy | Immunotherapy | Biological treatment | Investigational New Drugs

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0279025
UMLS CUI [4]
C0021083
UMLS CUI [5]
C1531518
UMLS CUI [6]
C0013230
unable to receive medications oral medications
Descrição

Oral medication Receive Unable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
major surgery within 28 days before cycle 1 day 1
Descrição

Major surgery

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0679637
active infection requiring within 2 weeks prior to first dose of study drug
Descrição

Communicable Disease Treatment required for

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0332121
patients who have hiv, hepatitis a, b or c or cmv reactivation
Descrição

HIV Infection | Hepatitis A | Hepatitis B | Hepatitis C | Cytomegalovirus Infection Reactivation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0019159
UMLS CUI [3]
C0019163
UMLS CUI [4]
C0019196
UMLS CUI [5,1]
C0010823
UMLS CUI [5,2]
C4086768
significant neurotoxicity/neuropathy (grade 3 or higher) within 14 days of first dose of study drug
Descrição

Neurotoxicity CTCAE Grades | Neuropathy CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0235032
UMLS CUI [1,2]
C1516728
UMLS CUI [2,1]
C0442874
UMLS CUI [2,2]
C1516728
conditions that could interfere with treatment or protocol-related procedures
Descrição

Condition Interferes with Therapy | Condition Interferes with Interventional procedure

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0087111
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0184661
Voltar ao início da página

Similar models

Eligibility Solid Tumors NCT02071862

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Malignant Neoplasms Advanced Recurrent | Malignant Neoplasms Advanced Unresponsive to Treatment | Therapy All Benefit | Patients Standard therapy Refused
Item
advanced malignancy that is relapsed and/or refractory to all available therapies that will confer clinical benefit. newly diagnosed patients who refuse standard treatment regimens are also eligible
boolean
C0006826 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C0444868 (UMLS CUI [3,2])
C0814225 (UMLS CUI [3,3])
C0030705 (UMLS CUI [4,1])
C2936643 (UMLS CUI [4,2])
C1705116 (UMLS CUI [4,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0-1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
Liver function | Renal function | Cardiac function | Hematologic function
Item
adequate hepatic, renal, cardiac, and hematologic function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232164 (UMLS CUI [3])
C0221130 (UMLS CUI [4])
Measurable Disease
Item
measurable disease by recist criteria
boolean
C1513041 (UMLS CUI [1])
Informed Consent
Item
ability to provide written informed consent in accordance with federal, local, and institutional guidelines
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cancer Other
Item
any other current or previous malignancy
boolean
C1707251 (UMLS CUI [1])
Chemotherapy | Therapeutic radiology procedure | Hormone Therapy | Immunotherapy | Biological treatment | Investigational New Drugs
Item
chemotherapy, radiation therapy, hormonal therapy, immunotherapy or biological therapy, or investigational agent within 21 days
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0021083 (UMLS CUI [4])
C1531518 (UMLS CUI [5])
C0013230 (UMLS CUI [6])
Oral medication Receive Unable
Item
unable to receive medications oral medications
boolean
C0175795 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Major surgery
Item
major surgery within 28 days before cycle 1 day 1
boolean
C0679637 (UMLS CUI [1])
Communicable Disease Treatment required for
Item
active infection requiring within 2 weeks prior to first dose of study drug
boolean
C0009450 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
HIV Infection | Hepatitis A | Hepatitis B | Hepatitis C | Cytomegalovirus Infection Reactivation
Item
patients who have hiv, hepatitis a, b or c or cmv reactivation
boolean
C0019693 (UMLS CUI [1])
C0019159 (UMLS CUI [2])
C0019163 (UMLS CUI [3])
C0019196 (UMLS CUI [4])
C0010823 (UMLS CUI [5,1])
C4086768 (UMLS CUI [5,2])
Neurotoxicity CTCAE Grades | Neuropathy CTCAE Grades
Item
significant neurotoxicity/neuropathy (grade 3 or higher) within 14 days of first dose of study drug
boolean
C0235032 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0442874 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Condition Interferes with Therapy | Condition Interferes with Interventional procedure
Item
conditions that could interfere with treatment or protocol-related procedures
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial